What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
—
Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.
https://www.propublica.org/article/zolgensma-sma-novartis-drug-prices-gene-therapy-avexis?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
#News #Health #Healthcare #Medicine #Genetics #Biotech #Science
ProPublica /
npub19f…gulzp
2025-02-12 14:30:04
Author Public Key
npub19fwwstv5dg8qsmuj9rmgf98nt9lfz5gvv67jqx6y9jtgekpcz5pqpgulzpPublished at
2025-02-12 14:30:04Event JSON
{
"id": "a9c6b8ddf3bd8cff922bfadd1a046a42e248dbc96fb860471617b1a91ee0892a",
"pubkey": "2a5ce82d946a0e086f9228f68494f3597e91510c66bd201b442c968cd8381502",
"created_at": 1739370604,
"kind": 1,
"tags": [
[
"t",
"News"
],
[
"t",
"health"
],
[
"t",
"healthcare"
],
[
"t",
"medicine"
],
[
"t",
"genetics"
],
[
"t",
"biotech"
],
[
"t",
"Science"
],
[
"proxy",
"https://newsie.social/users/ProPublica/statuses/113991391952975045",
"activitypub"
]
],
"content": "What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing\n—\n\nTaxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.\n\nhttps://www.propublica.org/article/zolgensma-sma-novartis-drug-prices-gene-therapy-avexis?utm_source=mastodon\u0026utm_medium=social\u0026utm_campaign=mastodon-post\n\n#News #Health #Healthcare #Medicine #Genetics #Biotech #Science",
"sig": "784fe38c85f633d99d49ed8848fdfa16983f08ea602ae28a699be37345457419b70d6ab3b019266d421c1f128695788753a43e7b83987dede8411e516fae5415"
}